Nanoparticle with a KSP siRNA and Pretubulysin, a microtubule targeting agent, resulted in increased anticancer activity in epidermal growth factor receptor (EGFR) overexpressing cancer cells when compared to both KSP siRNA and Pretubulysin alone [213]. Here, EGFR is linked to cancer.